We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly Petitions US Supreme Court to Review Gemzar Patent Decision
Lilly Petitions US Supreme Court to Review Gemzar Patent Decision
February 15, 2011
Eli Lilly has filed a petition for a writ of certiorari with the U.S. Supreme Court to review a federal appeals court’s July decision invalidating the company’s ’826 patent on Gemzar, which led to the introduction of generics in November.